MANCR and neoplasm: The dysregulated expression levels of MANCR were reported in thyroid carcinoma, gastric carcinoma, and esophagus cancer (Yao et al., 2019; Huang et al., 2020; Fan and Wang, 2021), thus enhancing tumor malignant development.